Education
About Us
Working with TipRanks
Follow Us
Fulgent Genetics (FLGT)
:FLGT
Earnings Data
Report Date
Feb 26, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.22Last Year’s EPS
0.04Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call presented a positive outlook with significant growth in laboratory services and advancements in therapeutic development. Despite some challenges with Anatomic Pathology collections and a GAAP loss, the company's overall financial health and strategic initiatives suggest strong momentum.Company Guidance
Laboratory Services Revenue Growth
Laboratory services revenue reached nearly $84 million, with Precision Diagnostics up $3.4 million (7.3% sequentially) and $7.2 million (16.4% year-over-year). Biopharma was up $1 million (15.4% sequentially) and $3.3 million (83.4% year-over-year).
Therapeutic Development Advancements
FID-007 is progressing well in Phase II trials, showing a 51% overall objective response rate and improved progression-free survival of 7.8 months versus the historical 2.3 months. A total of 43 patients are enrolled with full data expected in 2026.
New Product Launches in Precision Diagnostics
Launch of ultrarapid whole genome sequencing service and expansion of Beacon carrier screening service to 1,000 genes, which aims to improve diagnostic yield and patient outcomes, particularly in the NICU.
Financial Performance and Guidance
The company raised its full-year 2025 revenue outlook to $325 million, representing a 15% growth year-over-year. Non-GAAP gross margins expected to exceed 40% for the year.
FLGT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
FLGT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 07, 2025 | $22.31 | $26.36 | +18.15% |
Aug 01, 2025 | $17.18 | $18.53 | +7.86% |
May 02, 2025 | $17.25 | $20.54 | +19.07% |
Feb 28, 2025 | $15.69 | $15.45 | -1.53% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Fulgent Genetics (FLGT) report earnings?
Fulgent Genetics (FLGT) is schdueled to report earning on Feb 26, 2026, After Close (Confirmed).
What is Fulgent Genetics (FLGT) earnings time?
Fulgent Genetics (FLGT) earnings time is at Feb 26, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is FLGT EPS forecast?
FLGT EPS forecast for the fiscal quarter 2025 (Q4) is -0.22.